Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

AII vs AHG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AII Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 9–1 Matrix Metrics)

AII Overall Winner 6-Pillar Tally: AII 4 – 1 AHG (1 Tie) Matrix Metrics: AII 9 – 1 AHG

As of Nov 20, 2026, American Integrity Insurance Group, Inc. (AII) is the stronger overall head-to-head candidate over Akso Health Group ADS (AHG) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AII carries a Unified Composite Score of 44.2/100 (HOLD) at $28.60 (7.9x Forward P/E, 36.4% operating margin), whereas AHG carries 38.2/100 (SELL) at $1.26 (N/M Forward P/E, -28.9% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AII vs AHG
AII NYSE Head-to-Head Winner
American Integrity Insurance Group, Inc.
Fire, Marine & Casualty Insurance
$28.60
-1.79% 1D
Market Cap $570.6M
TTM Revenue $388M
Forward P/E 7.9x
Beta / 30D Vol 0.13β · 42% Vol
Unified Composite Score
44.2 / 100 HOLD
Tech 20.0 Fund 39.0 Flow 50.0 Mom 1.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (4.4% over 20 days), RSI 52
RSI-14: 52.2 · SMA20: $28.62 · SMA50: $27.43
AHG NASDAQ
Akso Health Group ADS
Services-Business Services, Nec
$1.26
-1.56% 1D
Market Cap $1.1B
TTM Revenue $14M
Forward P/E N/M
Beta / 30D Vol 0.38β · 101% Vol
Unified Composite Score
38.2 / 100 SELL
Tech 20.0 Fund 39.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 50
RSI-14: 49.6 · SMA20: $1.30 · SMA50: $1.14

6-Pillar Scorecard Institutional Category Breakdown (AII 4 – 1 AHG)

Columns: Metric · AII · AHG
1. Valuation Multiples AII
Forward P/E 7.9x N/M
Trailing P/E 5.6x N/M
PEG Ratio N/M N/M
EV / Revenue 1.5x 79.3x
2. Growth & Scale AII
Revenue Growth (YoY) +83.0% -12.9%
Earnings Growth (YoY) +114.9% +0.0%
TTM Revenue (USD) $388M $14M
Market Cap $570.6M $1.1B
3. Profitability & Quality AII
Gross Margin 51.8% -0.1%
Operating Margin 36.4% -28.9%
Net Profit Margin 26.6% -135.0%
Return on Equity (ROE) 29.2% -9.8%
4. Balance Sheet & Cash Flow AII
Cash Generation (TTM) $143M EBITDA -$1.6M EBITDA
Cash Flow Margin 36.9% EBITDA Mgn -11.8% EBITDA Mgn
Net Cash / Leverage $19.96 Book/Sh · 29.2% ROE $0.21 Book/Sh · -9.8% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Neutral
6. R&D & Supply-Chain Moat AHG
OpEx & R&D Intensity 15.4% of Rev ($60M) 28.8% of Rev ($4.0M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Insurance - Property & Casualty Operator Medical Distribution Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AII (9) vs AHG (1)
Institutional Metric AII AHG Criterion Row Edge
Market Capitalization
Scale
$570.6M $1.1B Larger Scale AHG
Trailing P/E Ratio
Valuation
5.6x N/M Lower Multiple AII
Forward P/E Ratio
Valuation
7.9x N/M Lower Multiple AII
Revenue Growth (YoY)
Growth
+83.0% -12.9% Higher Growth AII
Operating Margin (TTM)
Profitability
36.4% -28.9% Higher Margin AII
Net Profit Margin
Profitability
26.6% -135.0% Higher Margin AII
Return on Equity (ROE)
Capital Efficiency
29.2% -9.8% Higher ROE AII
52-Week Range Position
Momentum
78% ($16–$32) 32% ($1–$2) Stronger Trend AII
Beta / 30D Volatility
Risk Regime
0.13β · 42% Vol 0.38β · 101% Vol Lower Realized Risk AII
Unified Institutional Score
Composite Signal
44.2 / 100 (HOLD) 38.2 / 100 (SELL) Higher Composite AII
Trailing 12M Revenue (USD)
Operating Scale
$388M $14M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
51.8% -0.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.5x EV/Rev N/M PEG · 79.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$143M EBITDA ($19.96 Book/Sh · 29.2% ROE) -$1.6M EBITDA ($0.21 Book/Sh · -9.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AHG +5.23 pp
AII: -1.95% · AHG: +3.28%
3M Horizon AHG +24.23 pp
AII: +9.37% · AHG: +33.6%
6M Horizon AII +86.19 pp
AII: +69.63% · AHG: -16.56%
1Y Horizon AII +55.41 pp
AII: +37.76% · AHG: -17.65%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AII vs AHG. Trailing 12-month operating profitability (AII 36.4% vs AHG -28.9%) and valuation multiples (AII 7.9x vs AHG N/M Forward P/E) are benchmarked directly in Pillar 4 below.

AII ADR TTM Benchmark FX-Normalized USD
TTM Revenue$388M
Gross Margin51.8%
Op. Margin36.4%
ROE / Fwd P/E29.2% · 7.9x
AHG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$14M
Gross Margin-0.1%
Op. Margin-28.9%
ROE / Fwd P/E-9.8% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AII UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AII Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AHG UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew Thin ADR Chain
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AHG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AII Moat Profile High-Margin Pricing Power Moat
Insurance - Property & Casualty Operator
Competes within the Insurance - Property & Casualty value chain with $570.6M market capitalization and 36.4% operating margin.
OpEx & R&D Reinvestment 15.4% of Rev ($60M)
90D Engineering Disclosures 0 Published
AHG Moat Profile Cyclical / Execution-Driven Positioning
Medical Distribution Operator
Competes within the Medical Distribution value chain with $1.1B market capitalization and -28.9% operating margin.
OpEx & R&D Reinvestment 28.8% of Rev ($4.0M)
90D Engineering Disclosures 0 Published

Investor FAQ AII vs AHG Key Questions & Quantitative Answers

As of Nov 20, 2026, American Integrity Insurance Group, Inc. (AII) is the stronger overall head-to-head candidate over Akso Health Group ADS (AHG) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AII carries a Unified Composite Score of 44.2/100 (HOLD) at $28.60 (7.9x Forward P/E, 36.4% operating margin), whereas AHG carries 38.2/100 (SELL) at $1.26 (N/M Forward P/E, -28.9% operating margin). Technically, AII sits in a Markup phase (RSI 52.2, UNCLASSIFIED options structure) and AHG sits in a Neutral phase (RSI 49.6, UNCLASSIFIED options structure).

AII leads the Growth & Scale pillar: AII posts +83.0% YoY revenue growth and +114.9% YoY earnings growth on $388M TTM revenue (51.8% gross margin, 36.4% operating margin), compared with AHG at -12.9% YoY revenue growth and +0.0% YoY earnings growth on $14M TTM revenue (-0.1% gross margin, -28.9% operating margin). On trailing 12-month operating scale, AII generates $388M in USD-normalized revenue versus $14M for AHG. In operating R&D and SG&A reinvestment, AII deploys 15.4% of Rev ($60M) (0 90-day corporate R&D disclosures) versus 28.8% of Rev ($4.0M) (0 disclosures) for AHG.

AII screens cheaper on headline valuation multiples. AII trades at 7.9x Forward P/E, 5.6x Trailing P/E, N/M PEG, and 1.5x EV/Revenue (36.9% EBITDA margin), whereas AHG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 79.3x EV/Revenue (-11.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AII (29.2% ROE) versus AHG (-9.8% ROE) capital efficiency.

In options market volatility and institutional positioning, AII carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.13β · 42% Vol realized risk). By comparison, AHG carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.38β · 101% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.